These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 37033238)

  • 21. A Review of Current Clinical Concepts in the Pathophysiology, Etiology, Diagnosis, and Management of Hypercalcemia.
    Tonon CR; Silva TAAL; Pereira FWL; Queiroz DAR; Junior ELF; Martins D; Azevedo PS; Okoshi MP; Zornoff LAM; de Paiva SAR; Minicucci MF; Polegato BF
    Med Sci Monit; 2022 Feb; 28():e935821. PubMed ID: 35217631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation and therapy of hypercalcemia.
    Khoury N; Carmichael KA
    Mo Med; 2011; 108(2):99-103. PubMed ID: 21568230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypercalcemia of malignancy: a review of advances in pathophysiology.
    Kaplan M
    Oncol Nurs Forum; 1994 Jul; 21(6):1039-46; quiz 1047-8. PubMed ID: 7971410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypercalcemia of malignancy treated with cinacalcet.
    Asonitis N; Kassi E; Kokkinos M; Giovanopoulos I; Petychaki F; Gogas H
    Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 29399364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy of malignancy-associated hypercalcemia: 1983.
    Stewart AF
    Am J Med; 1983 Mar; 74(3):475-80. PubMed ID: 6219580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of hypercalcaemia of malignancy in adults.
    Mc Donald D; Drake MT; Crowley RK
    Clin Med (Lond); 2023 Sep; 23(5):503-507. PubMed ID: 37775175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypercalcemia: mechanisms, differential diagnosis, and remedies.
    Deftos LJ
    Postgrad Med; 1996 Dec; 100(6):119-21, 125-6. PubMed ID: 8960013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical management of hypercalcaemia.
    Ralston SH
    Br J Clin Pharmacol; 1992 Jul; 34(1):11-20. PubMed ID: 1633063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypercalcemic crisis.
    Edelson GW; Kleerekoper M
    Med Clin North Am; 1995 Jan; 79(1):79-92. PubMed ID: 7808096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypercalcemia: A Review.
    Walker MD; Shane E
    JAMA; 2022 Oct; 328(16):1624-1636. PubMed ID: 36282253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypercalcemia of Malignancy: An Update on Pathogenesis and Management.
    Mirrakhimov AE
    N Am J Med Sci; 2015 Nov; 7(11):483-93. PubMed ID: 26713296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of malignancy-associated hypercalcemia].
    Endo I; Inoue D
    Clin Calcium; 2006 Apr; 16(4):665-69. PubMed ID: 16582519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haematological emergencies managing hypercalcaemia in adults and children with haematological disorders.
    Sargent JT; Smith OP
    Br J Haematol; 2010 May; 149(4):465-77. PubMed ID: 20377591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of cancer-related hypercalcemia: the role of gallium nitrate.
    Leyland-Jones B
    Semin Oncol; 2003 Apr; 30(2 Suppl 5):13-9. PubMed ID: 12776255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypercalcemia of malignancy and new treatment options.
    Sternlicht H; Glezerman IG
    Ther Clin Risk Manag; 2015; 11():1779-88. PubMed ID: 26675713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated levels of circulating fibroblast growth factor 23 with hypercalcemia following discontinuation of denosumab.
    Uchida T; Yamaguchi H; Kushima C; Yonekawa T; Nakazato M
    Endocr J; 2020 Jan; 67(1):31-35. PubMed ID: 31527321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immobilisation hypercalcaemia.
    Mifsud S; Mifsud EL; Agius SM; Mula A; Gruppetta M
    Br J Hosp Med (Lond); 2022 Jun; 83(6):1-7. PubMed ID: 35787163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overview of hypercalcemia of malignancy.
    Solimando DA
    Am J Health Syst Pharm; 2001 Nov; 58 Suppl 3():S4-7. PubMed ID: 11757205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Denosumab normalized plasma calcium concentration in malignancy-associated hypercalcaemia].
    Størling L; Villadsen GE; Krogh K; Vestergaard P
    Ugeskr Laeger; 2014 Jul; 176(30):. PubMed ID: 25292242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
    McMahan J; Linneman T
    Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.